Published in J Infect Dis on May 15, 2003
Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci (2004) 4.60
Photodynamic therapy targeted to pathogens. Int J Immunopathol Pharmacol (2004) 1.93
Photodynamic therapy for localized infections--state of the art. Photodiagnosis Photodyn Ther (2009) 1.73
Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob Agents Chemother (2006) 1.58
Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem Photobiol Sci (2004) 1.57
Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice. Biomaterials (2006) 1.51
Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria. J Photochem Photobiol B (2005) 1.50
Noninvasive biophotonic imaging for studies of infectious disease. FEMS Microbiol Rev (2010) 1.44
Photodynamic therapy for infections: clinical applications. Lasers Surg Med (2011) 1.42
In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent. BMC Microbiol (2009) 1.40
Antimicrobial photodynamic therapy combined with conventional endodontic treatment to eliminate root canal biofilm infection. Lasers Surg Med (2007) 1.33
In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals. Sensors (Basel) (2010) 1.33
Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother (2004) 1.31
Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci (2005) 1.29
Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria. Antimicrob Agents Chemother (2007) 1.21
Effect of chitosan acetate bandage on wound healing in infected and noninfected wounds in mice. Wound Repair Regen (2008) 1.11
Antimicrobial photodynamic inactivation and photodynamic therapy for infections. Methods Mol Biol (2010) 1.11
Deficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa. J Immunol (2006) 1.11
Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond) (2010) 1.09
Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice. Antimicrob Agents Chemother (2011) 1.07
Assessment of photodynamic destruction of Escherichia coli O157:H7 and Listeria monocytogenes by using ATP bioluminescence. Appl Environ Microbiol (2003) 1.06
All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease. Virulence (2011) 1.05
Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl Environ Microbiol (2005) 1.02
Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond. Curr Opin Pharmacol (2013) 1.02
Paradoxical potentiation of methylene blue-mediated antimicrobial photodynamic inactivation by sodium azide: role of ambient oxygen and azide radicals. Free Radic Biol Med (2012) 1.00
Involvement of skeletal muscle gene regulatory network in susceptibility to wound infection following trauma. PLoS One (2007) 1.00
In vivo imaging of bioluminescent Escherichia coli in a cutaneous wound infection model for evaluation of an antibiotic therapy. Antimicrob Agents Chemother (2004) 1.00
Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob Agents Chemother (2005) 0.96
ELECTROPHYSICAL AGENTS - Contraindications And Precautions: An Evidence-Based Approach To Clinical Decision Making In Physical Therapy. Physiother Can (2011) 0.94
A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens. J Infect Chemother (2007) 0.93
Antimicrobial photodynamic therapy to kill Gram-negative bacteria. Recent Pat Antiinfect Drug Discov (2013) 0.93
Antimicrobial blue light inactivation of Candida albicans: In vitro and in vivo studies. Virulence (2016) 0.93
Down-regulation of glutatione S-transferase α 4 (hGSTA4) in the muscle of thermally injured patients is indicative of susceptibility to bacterial infection. FASEB J (2011) 0.92
Drug discovery of antimicrobial photosensitizers using animal models. Curr Pharm Des (2011) 0.92
Use of a bioluminescent Pseudomonas aeruginosa strain within an in vitro microbiological system, as a model of wound infection, to assess the antimicrobial efficacy of wound dressings by monitoring light production. Antimicrob Agents Chemother (2007) 0.91
Topical photodynamic treatment with poly-L-lysine-chlorin p6 conjugate improves wound healing by reducing hyperinflammatory response in Pseudomonas aeruginosa-infected wounds of mice. Lasers Med Sci (2012) 0.90
Rapid dissemination of Francisella tularensis and the effect of route of infection. BMC Microbiol (2008) 0.90
Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects. World J Immunol (2014) 0.87
Lethal photosensitization of wound-associated microbes using indocyanine green and near-infrared light. BMC Microbiol (2008) 0.87
Can biowarfare agents be defeated with light? Virulence (2013) 0.86
Efficient photodynamic therapy against gram-positive and gram-negative bacteria using THPTS, a cationic photosensitizer excited by infrared wavelength. PLoS One (2010) 0.86
UVC light prophylaxis for cutaneous wound infections in mice. Antimicrob Agents Chemother (2012) 0.85
Safety assessment of oral photodynamic therapy in rats. Lasers Med Sci (2012) 0.85
Photoinactivation of Mycobacteria in vitro and in a new murine model of localized Mycobacterium bovis BCG-induced granulomatous infection. Antimicrob Agents Chemother (2006) 0.84
Photodynamic therapy induces an immune response against a bacterial pathogen. Expert Rev Clin Immunol (2012) 0.82
Toluidine blue-mediated photodynamic therapy of oral wound infections in rats. Lasers Med Sci (2009) 0.82
Molecular imaging of pulmonary disease in vivo. Proc Am Thorac Soc (2009) 0.80
Eradication of bacteria in suspension and biofilms using methylene blue-loaded dynamic nanoplatforms. Antimicrob Agents Chemother (2009) 0.79
Photonic real-time monitoring of bacterial reduction in root canals by genetically engineered bacteria after chemomechanical endodontic therapy. Braz Dent J (2007) 0.79
Animal models for photodynamic therapy (PDT). Biosci Rep (2015) 0.79
Effects of low intensity laser irradiation during healing of infected skin wounds in the rat. Photonics Lasers Med (2014) 0.79
Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes. Curr Opin Microbiol (2016) 0.78
Photodynamic inactivation of bacteria using polyethylenimine-chlorin(e6) conjugates: Effect of polymer molecular weight, substitution ratio of chlorin(e6) and pH. Lasers Surg Med (2011) 0.78
Antimicrobial blue light inactivation of Pseudomonas aeruginosa by photo-excitation of endogenous porphyrins: In vitro and in vivo studies. Lasers Surg Med (2016) 0.77
Linezolid and vancomycin decrease the therapeutic effect of methylene blue-photodynamic therapy in a mouse model of MRSA bacterial arthritis. Photochem Photobiol (2013) 0.77
Laser treatment of recurrent herpes labialis: a literature review. Lasers Med Sci (2013) 0.77
Nanotechnology for photodynamic therapy: a perspective from the Laboratory of Dr. Michael R. Hamblin in the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School. Nanotechnol Rev (2015) 0.75
Antimicrobial Blue Light Inactivation of Gram-Negative Pathogens in Biofilms: In Vitro and In Vivo Studies. J Infect Dis (2016) 0.75
Murine Model Imitating Chronic Wound Infections for Evaluation of Antimicrobial Photodynamic Therapy Efficacy. Front Microbiol (2016) 0.75
Antimicrobial Blue Light Therapy for Infectious Keratitis: Ex Vivo and In Vivo Studies. Invest Ophthalmol Vis Sci (2017) 0.75
Infected animal models for tissue engineering. Methods (2015) 0.75
Potassium iodide potentiates antimicrobial photodynamic inactivation mediated by Rose Bengal: in vitro and in vivo studies. Antimicrob Agents Chemother (2017) 0.75
A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem (1978) 38.54
Photodynamic therapy. J Natl Cancer Inst (1998) 12.83
Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect (2000) 7.50
Photonic detection of bacterial pathogens in living hosts. Mol Microbiol (1995) 5.24
Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis (1999) 4.75
Simplified agar plate method for quantifying viable bacteria. Biotechniques (1997) 3.90
Monitoring bioluminescent Staphylococcus aureus infections in living mice using a novel luxABCDE construct. Infect Immun (2000) 3.62
Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother (1998) 3.26
Burn wound infections: current status. World J Surg (1998) 2.86
Photophysical and photobiological processes in the photodynamic therapy of tumours. J Photochem Photobiol B (1997) 2.25
Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection. Antimicrob Agents Chemother (2001) 2.22
Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol (2002) 2.18
Pseudomonas aeruginosa elastase and its role in pseudomonas infections. Rev Infect Dis (1984) 2.14
Gamma globulin factors protective against infections from Pseudomonas and other organisms. Science (1957) 2.12
Targeted antimicrobial photochemotherapy. Antimicrob Agents Chemother (1998) 1.79
Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis (1994) 1.69
Real-time monitoring of Escherichia coli O157:H7 adherence to beef carcass surface tissues with a bioluminescent reporter. Appl Environ Microbiol (1999) 1.40
Current treatment recommendations for topical burn therapy. Drugs (1990) 1.35
The effect of photodynamic action on two virulence factors of gram-negative bacteria. Photochem Photobiol (2000) 1.30
Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 1.25
Avirulence of a Pseudomonas aeruginosa algC mutant in a burned-mouse model of infection. Infect Immun (1995) 1.20
PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice. Infect Immun (2001) 1.16
Pseudomonas aeruginosa bacteremia in immunocompromised children: analysis of factors associated with a poor outcome. Clin Infect Dis (1994) 1.14
Antibody-targeted photolysis of bacteria in vivo. Biotechnology (N Y) (1994) 1.11
Pulmonary infiltrates in the cancer patient. New approaches to an old problem. Infect Dis Clin North Am (1996) 1.02
Local and systemic therapy of pseudomonas septicemia in burned mice. Ann Surg (1967) 1.02
Photoeradication of Helicobacter pylori using 5-aminolevulinic acid: preliminary human studies. Lasers Surg Med (2002) 1.01
The Pseudomonas aeruginosa outer membrane permeability barrier and how to overcome it. Antibiot Chemother (1971) (1985) 1.00
A history of photodynamic therapy. Aust N Z J Surg (1991) 0.94
Secular trends in nosocomial bloodstream infections in a 55-bed cardiothoracic intensive care unit. Ann Thorac Surg (1998) 0.94
An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5alpha and EQ1. J Appl Microbiol (2000) 0.92
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature (2004) 5.61
Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat Med (2008) 4.83
Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci (2004) 4.60
Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A (2003) 4.41
Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol (2004) 4.16
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood (2006) 3.33
Dual-axis confocal microscope for high-resolution in vivo imaging. Opt Lett (2003) 3.16
In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood (2005) 3.13
Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci U S A (2010) 2.89
In vivo flow cytometry: a new method for enumerating circulating cancer cells. Cancer Res (2004) 2.84
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood (2002) 2.79
Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J Biomed Opt (2005) 2.69
Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science (2004) 2.58
Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev (2010) 2.44
Chemical control of protein stability and function in living mice. Nat Med (2008) 2.37
Synergistic antitumor effects of immune cell-viral biotherapy. Science (2006) 2.37
Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation (2008) 2.22
Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol (2002) 2.18
Dual-axes confocal reflectance microscope for distinguishing colonic neoplasia. J Biomed Opt (2006) 2.17
In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease. Nat Rev Immunol (2006) 2.06
Miniature near-infrared dual-axes confocal microscope utilizing a two-dimensional microelectromechanical systems scanner. Opt Lett (2007) 2.06
Efficient rejection of scattered light enables deep optical sectioning in turbid media with low-numerical-aperture optics in a dual-axis confocal architecture. J Biomed Opt (2008) 1.99
Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J Natl Cancer Inst (2005) 1.98
Guided by the light: visualizing biomolecular processes in living animals with bioluminescence. Curr Opin Chem Biol (2009) 1.97
Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells (2007) 1.93
Design and evaluation of a variable aperture collimator for conformal radiotherapy of small animals using a microCT scanner. Med Phys (2007) 1.90
In vivo bioluminescence imaging for integrated studies of infection. Cell Microbiol (2004) 1.89
Polycationic photosensitizer conjugates: effects of chain length and Gram classification on the photodynamic inactivation of bacteria. J Antimicrob Chemother (2002) 1.88
Functional imaging of colonic mucosa with a fibered confocal microscope for real-time in vivo pathology. Clin Gastroenterol Hepatol (2007) 1.85
Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. Transplantation (2005) 1.82
In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J (2005) 1.80
Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation (2009) 1.73
Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters. Proc Natl Acad Sci U S A (2008) 1.71
Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1. J Mol Med (Berl) (2002) 1.70
Heme oxygenase-1 deficiency leads to disrupted response to acute stress in stem cells and progenitors. Blood (2008) 1.70
Development of therapeutic siRNAs for pachyonychia congenita. J Invest Dermatol (2007) 1.67
Detecting epidermal growth factor receptor tumor activity in vivo during cetuximab therapy of murine gliomas. Acad Radiol (2009) 1.67
Luciferin derivatives for enhanced in vitro and in vivo bioluminescence assays. Biochemistry (2006) 1.67
Generic and personalized RNAi-based therapeutics for a dominant-negative epidermal fragility disorder. J Invest Dermatol (2012) 1.66
Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Mol Pharm (2009) 1.61
Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem Photobiol Sci (2004) 1.57
Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria. J Photochem Photobiol B (2005) 1.50
In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging. Mol Imaging Biol (2012) 1.49
Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications. Clin Cancer Res (2006) 1.49
In vivo near-infrared dual-axis confocal microendoscopy in the human lower gastrointestinal tract. J Biomed Opt (2012) 1.49
Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Blood (2007) 1.48
Effect of a chitosan-based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. J Trauma (2003) 1.47
Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. J Invest Dermatol (2007) 1.46
Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am J Pathol (2009) 1.44
Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr (2006) 1.41
Global analysis of Smad2/3-dependent TGF-beta signaling in living mice reveals prominent tissue-specific responses to injury. J Immunol (2005) 1.39
p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia. J Immunol (2004) 1.36
Three-dimensional in vivo imaging by a handheld dual-axes confocal microscope. Opt Express (2008) 1.35
Intracellular cargo delivery by an octaarginine transporter adapted to target prostate cancer cells through cell surface protease activation. Bioconjug Chem (2006) 1.35
Quantifying cell-surface biomarker expression in thick tissues with ratiometric three-dimensional microscopy. Biophys J (2009) 1.33
Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother (2004) 1.31
Hemin-activated macrophages home to the pancreas and protect from acute pancreatitis via heme oxygenase-1 induction. J Clin Invest (2005) 1.31
Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease. Blood (2006) 1.31
Pretreatment photosensitizer dosimetry reduces variation in tumor response. Int J Radiat Oncol Biol Phys (2006) 1.31
Animal models of bone metastasis. Cancer (2003) 1.29
Development and applications of photo-triggered theranostic agents. Adv Drug Deliv Rev (2010) 1.29
Dual-axes confocal microscopy with post-objective scanning and low-coherence heterodyne detection. Opt Lett (2003) 1.29
Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci (2005) 1.29
Micromirror-scanned dual-axis confocal microscope utilizing a gradient-index relay lens for image guidance during brain surgery. J Biomed Opt (2010) 1.27
Strategies for enhanced photodynamic therapy effects. Photochem Photobiol (2007) 1.27
Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res (2010) 1.27
Enhancing poxvirus oncolytic effects through increased spread and immune evasion. Cancer Res (2008) 1.26
Monitoring age-related susceptibility of young mice to oral Salmonella enterica serovar Typhimurium infection using an in vivo murine model. Pediatr Res (2005) 1.26
Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model. J Biomed Opt (2010) 1.25
Evaluation of effector cell fate and function by in vivo bioluminescence imaging. Methods (2003) 1.25
Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng (2005) 1.23
Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules. Proc Natl Acad Sci U S A (2013) 1.23
Releasable luciferin-transporter conjugates: tools for the real-time analysis of cellular uptake and release. J Am Chem Soc (2006) 1.23
Quantitative imaging of scattering changes associated with epithelial proliferation, necrosis, and fibrosis in tumors using microsampling reflectance spectroscopy. J Biomed Opt (2009) 1.23
Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. PLoS One (2011) 1.22
Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood (2002) 1.21
Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine. J Infect Dis (2005) 1.20
In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment. Clin Cancer Res (2008) 1.20
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Clin Cancer Res (2006) 1.20
Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo. Clin Cancer Res (2009) 1.20
A Raman-based endoscopic strategy for multiplexed molecular imaging. Proc Natl Acad Sci U S A (2013) 1.18
Imaging targeted-agent binding in vivo with two probes. J Biomed Opt (2010) 1.17
Confocal fluorescence microscope with dual-axis architecture and biaxial postobjective scanning. J Biomed Opt (2004) 1.16
Detection of endogenous biomolecules in Barrett's esophagus by Fourier transform infrared spectroscopy. Proc Natl Acad Sci U S A (2007) 1.16
Characterization of coelenterazine analogs for measurements of Renilla luciferase activity in live cells and living animals. Mol Imaging (2004) 1.16
Targeting localized immune suppression within the tumor through repeat cycles of immune cell-oncolytic virus combination therapy. Mol Ther (2010) 1.15
In vivo micro-image mosaicing. IEEE Trans Biomed Eng (2010) 1.14
Induced biliary excretion of Listeria monocytogenes. Infect Immun (2006) 1.13
Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice. Proc Natl Acad Sci U S A (2007) 1.12
Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides (2003) 1.12
Comparison of gene expression after intraperitoneal delivery of AAV2 or AAV5 in utero. Mol Ther (2003) 1.12
A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer. Cancer Res (2006) 1.12
The T cell STAT signaling network is reprogrammed within hours of bacteremia via secondary signals. J Immunol (2009) 1.11
In vitro ovarian tumor growth and treatment response dynamics visualized with time-lapse OCT imaging. Opt Express (2009) 1.11
Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. Lasers Surg Med (2011) 1.11